# Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris

> **NCT03361345** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Wayne State University**

## Conditions studied

- Postinflammatory Hyperpigmentation

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03361345
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11-01
- **Primary completion:** 2022-01-09
- **Final completion:** 2022-01-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361345, "Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03361345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*